Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

UPS vs. EXPD: Which Dividend-Paying Stock Reigns Supreme Currently?
UPS vs. EXPD: Which Dividend-Paying Stock Reigns Supreme Currently?

United Parcel Service UPS and Expeditors International of Washington EXPD are two major players in the Zacks Transportation sector. Despite ongoing economic uncertainty, both companies increased

Tesla Registrations in November Plunge Across Key European Markets
Tesla Registrations in November Plunge Across Key European Markets

Tesla’s TSLA vehicle registrations in France and Denmark fell sharply in November. The registrations dropped by about half compared to last year, as the company continued to lose ground in the

Pre-markets Move Back into the Green, SIG Beats by +293%: https://staticx-tuner.zacks.com/images/articles/main/72/134753.webp
Pre-markets Move Back into the Green, SIG Beats by +293%

Tuesday, December 2, 2025Pre-market futures are bouncing back mildly — not strongly enough to be considered a “surge,” but still back in the right direction. After losing more than -400 points

Best Momentum Stocks to Buy for Dec.2
Best Momentum Stocks to Buy for Dec.2

Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 2: 

Compania de Minas Buenaventura S.A.A. BVN: This polymetallic mining company has a

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $3 Put had some of the highest

MIRM Enrolls First Patient in Phase II Fragile X Syndrome Study
MIRM Enrolls First Patient in Phase II Fragile X Syndrome Study

Mirum Pharmaceuticals MIRM announced that it has enrolled the first patient in the phase II BLOOM study evaluating its newly in-licensed PDE4D inhibitor, MRM-3379, for treating Fragile X syndrome

Is the Options Market Predicting a Spike in Bridgewater Bancshares Stock?
Is the Options Market Predicting a Spike in Bridgewater Bancshares Stock?

Investors in Bridgewater Bancshares, Inc. BWB need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2025 $10.00 Put had some of the

Can Altria Sustain EPS Gains as Revenues Decrease 1.7% Y/Y?
Can Altria Sustain EPS Gains as Revenues Decrease 1.7% Y/Y?

Altria Group, Inc.’s (MO) ability to deliver 3.6% growth in adjusted earnings per share (EPS) to $1.45 in the third quarter of 2025 contrasts with a 1.7% year-over-year decline in revenues net of

The Zacks Analyst Blog Highlights NVIDIA, Palantir Technologies and Micron
The Zacks Analyst Blog Highlights NVIDIA, Palantir Technologies and Micron

For Immediate Release

Chicago, IL – December 2, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Blackstone & Others to Take Part in BoE Private Credit Stress Test
Blackstone & Others to Take Part in BoE Private Credit Stress Test

Blackstone, Inc. BX, KKR & Co. KKR and Apollo Global Management APO have agreed to take part in a Bank of England (“BoE”) private credit stress test aimed at gauging how the private credit markets

Is the Options Market Predicting a Spike in Arcutis Biotherapeutics Stock?
Is the Options Market Predicting a Spike in Arcutis Biotherapeutics Stock?

Investors in Arcutis Biotherapeutics, Inc. ARQT need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $5 Put had some of the highest

Are Options Traders Betting on a Big Move in BrainsWay Stock?
Are Options Traders Betting on a Big Move in BrainsWay Stock?

Investors in BrainsWay Ltd. BWAY need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $12.50 Put had some of the highest implied

Liberty Loses 2% in a Year: Should You Hold or Sell Now?
Liberty Loses 2% in a Year: Should You Hold or Sell Now?

Liberty Energy Inc. LBRT has lagged behind its peers, with shares down 1.9%, clearly underperforming relative to broader benchmarks. The Oil & Gas-Field Services sub-industry (ZSI131M) remained

Palo Alto Networks Plunges 14% in a Month: Time to Hold Tight or Exit?
Palo Alto Networks Plunges 14% in a Month: Time to Hold Tight or Exit?

Palo Alto Networks’(PANW) shares have lost 14.4% over the past month, underperforming the Zacks Security industry’s decline of 11.3%. The stock has also underperformed its industry peers and

JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis
JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis

Johnson & Johnson JNJ announced that the European Commission has approved Imaavy (nipocalimab) as an add-on therapy for the treatment of generalized myasthenia gravis (gMG) in adults and

Zacks Industry Outlook Highlights Criteo and NetEase
Zacks Industry Outlook Highlights Criteo and NetEase

For Immediate Release

Chicago, IL – December 2, 2025 – Today, Zacks Equity Research discusses Criteo S.A. CRTO and NetEase, Inc. NTES.

Industry: Internet Software & Services

Link: https://www.zacks.

Here's Why Investors Should Give Ryder System Stock a Miss Now
Here's Why Investors Should Give Ryder System Stock a Miss Now

Ryder System R is grappling with challenges arising from increased operating expenses, which are adversely impacting the company’s performance, making it an unattractive choice for investors’

USA Compression Announces Acquisition of J-W Power for $860 Million
USA Compression Announces Acquisition of J-W Power for $860 Million

USA Compression Partners, LP USAC, Dallas, TX, an oil and gas equipment and services provider, recently announced a definitive agreement to acquire J-W Power Company, a major privately-held player

Is the Options Market Predicting a Spike in Avery Dennison Stock?
Is the Options Market Predicting a Spike in Avery Dennison Stock?

Investors in Avery Dennison Corporation AVY need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $105.00 Put had some of the highest

3 Communication Stocks Likely to Weather Industry Headwinds: https://staticx-tuner.zacks.com/images/articles/main/cf/125899.webp
3 Communication Stocks Likely to Weather Industry Headwinds
The Zacks Diversified Communication Services industry appears mired in shrinking profit margins due to high capital expenditures for 5G infrastructure upgrades, unpredictable raw material prices
Centrus Energy's Q3 Revenues Up on Uranium Sales: More Upside Ahead?
Centrus Energy's Q3 Revenues Up on Uranium Sales: More Upside Ahead?

Centrus Energy LEU reported total revenues of $75 million in the third quarter of 2025, reflecting a 30% increase year over year. This was mainly attributed to improved results in its Low-Enriched

CAT Stock Trades at Premium Value: Should You Buy, Hold or Sell?
CAT Stock Trades at Premium Value: Should You Buy, Hold or Sell?

Caterpillar Inc. CAT is currently trading at a forward 12-month price/earnings (P/E) ratio of 26.32X compared with the manufacturing - construction and mining industry average of 24.59X.

With a

Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve

For Immediate Release

Chicago, IL – December 2, 2025 – Stocks in this week’s article are Life Time Group Holdings, Inc. LTH, Cardinal Health, Inc. CAH, LeMaitre Vascular, Inc. LMAT and Flowserve

Are Options Traders Betting on a Big Move in AvalonBay Stock?
Are Options Traders Betting on a Big Move in AvalonBay Stock?

Investors in AvalonBay Communities, Inc. AVB need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $115.00 Call had some of the

Analysts Estimate Campbell's (CPB) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Campbell's (CPB) to Report a Decline in Earnings: What to Look Out for

The market expects Campbell's (CPB) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended October 2025. This widely-known consensus outlook